Increasing resilience of medical supply chains during the COVID-19 pandemic
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
New survey data shows stabilizing investors outlook and increasing focus on environmental sustainability.
The recovery of supply chains can be supported through trade policies and firm-specific initiatives.
COVID-19 struck at the core of GVC hub regions, with severe implications for international production networks.